Drug Approval Package

 Commit (Nicotine Polacrilex) Lozenge
Company:  GlaxoSmithKline
Application No.:  021330
Approval Date: 10/31/2002

• Approval Letter(s) (PDF)

• Printed Labeling (PDF)

• Medical Review(s)
  Part 1 (PDF)  
  Part 2 (PDF)  

• Chemistry Review(s) (PDF)

• Pharmacology Review(s)
  Part 1 (PDF)  
  Part 2 (PDF)  

• Statistical Review(s) (PDF)

• Clinical Pharmacology Biopharmaceutics Review(s) (PDF)

• Administrative Document(s) & Correspondence
  Part 1 (PDF)  
  Part 2 (PDF)  

Date created: June 282004

Back to Top    Drugs@FDA

Note: Documents in PDF format require the Adobe Acrobat Reader®.